APA

Chen G., Xu Z., Chang G., Hou J., Hu L., Zhang Y., Yu D., Li B., Chang S., Xie Y., Zhang Y., Wei R., Wu H., Xiao W., Sun X., Tao Y., Gao L., Dai B., Shi J. & Zhu W. (20180326). The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells. : Oncology reports.

Chicago

Chen Gege, Xu Zhijian, Chang Gaomei, Hou Jun, Hu Liangning, Zhang Yiwen, Yu Dandan, Li Bo, Chang Shuaikang, Xie Yongsheng, Zhang Yong, Wei Rong, Wu Huiqun, Xiao Wenqin, Sun Xi, Tao Yi, Gao Lu, Dai Bojie, Shi Jumei and Zhu Weiliang. 20180326. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells. : Oncology reports.

Harvard

Chen G., Xu Z., Chang G., Hou J., Hu L., Zhang Y., Yu D., Li B., Chang S., Xie Y., Zhang Y., Wei R., Wu H., Xiao W., Sun X., Tao Y., Gao L., Dai B., Shi J. and Zhu W. (20180326). The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells. : Oncology reports.

MLA

Chen Gege, Xu Zhijian, Chang Gaomei, Hou Jun, Hu Liangning, Zhang Yiwen, Yu Dandan, Li Bo, Chang Shuaikang, Xie Yongsheng, Zhang Yong, Wei Rong, Wu Huiqun, Xiao Wenqin, Sun Xi, Tao Yi, Gao Lu, Dai Bojie, Shi Jumei and Zhu Weiliang. The blueberry component pterostilbene has potent anti-myeloma activity in bortezomib-resistant cells. : Oncology reports. 20180326.